The impact of health expenditures on public health in BRICS nations

被引：86

作者：

Jakovljevic, Mihajlo ^{[1
]}

Timofeyev, Yuriy ^{[2
]}

Ekkert, Natalia V. ^{[3
]}

Fedorova, Julia V. ^{[4
]}

Skvirskaya, Galina ^{[3
]}

Bolevich, Sergey ^{[5
]}

Reshetnikov, Vladimir A. ^{[3
]}

机构：

[1] Lund Univ, Div Hlth Econ, SE-22007 Lund, Sweden

[2] Natl Res Univ, Higher Sch Econ, Moscow 101000, Russia

[3] Sechenov First Moscow State Med Univ, Dept Hlth Care & Publ Hlth, Moscow 119991, Russia

[4] Sechenov First Moscow State Med Univ, Ctr Master Programs, Moscow 119991, Russia

[5] Sechenov First Moscow State Med Univ, Dept Human Pathol, Moscow 119991, Russia

来源：

关键词：

DISEASES; BURDEN;

D O I：

10.1016/j.jshs.2019.09.002

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：516 / 519

页数：4

共 19 条

[1] [Anonymous], GLOB HLTH EXP DAT
[2] Tackling inequitable public health burden of emerging and neglected diseases in BRICS countries
Ernest, T.
Xu, J.
Gao, S.
Chen, J. -H.
Hei, W.
Perelet, R.
Birtkoltz, L. M.
Xiaonong, Z.
[J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 234 - 235
[3] Igbal G., 2019, 2019 INT C CONT ED S
[4] Jakovljevic M. B., 2014, Serbian Journal of Experimental and Clinical Research, V15, P139, DOI [10.2478/sjecr-2014-0018, 10.5937/sjecr15-6706, DOI 10.2478/SJECR-2014-0018]
[5] Evolving Health Expenditure Landscape of the BRICS Nations and Projections to 2025
Jakovljevic, Mihajlo
Potapchik, Elena
Popovich, Larisa
Barik, Debasis
Getzen, Thomas E.
[J]. HEALTH ECONOMICS, 2017, 26 (07) : 844 - 852
[6] BRIC's growing share of global health spending and their diverging pathways
Jakovljevic, Mihajlo B.
[J]. FRONTIERS IN PUBLIC HEALTH, 2015, 3
[7] Growing burden of non-communicable diseases in the emerging health markets: the case of BRICS
Jakovljevic, Mihajlo B.
Milovanovic, Olivera
[J]. FRONTIERS IN PUBLIC HEALTH, 2015, 3
[8] Korotayev A, 2015, CRITICAL 10 YEARS DE, P125
[9] Kose A., 2017, Big emerging market economies versus the G7: Which group will drive the upswing in global growth?
[10] Menon S., 2019, J APPL PHARM SCI, V9, P135